106. Sci Rep. 2018 Mar 20;8(1):4899. doi: 10.1038/s41598-018-23099-7.Effect of CCL5 expression in the recruitment of immune cells in triple negativebreast cancer.Araujo JM(1), Gomez AC(2), Aguilar A(1), Salgado R(3), Balko JM(4), Bravo L(5),Doimi F(1), Bretel D(1)(6), Morante Z(1)(7), Flores C(1), Gomez HL(8)(9), PintoJA(1).Author information: (1)Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA, Lima, Peru.(2)Escuela de Ingeniería Biotecnológica, Universidad Católica de Santa María,Arequipa, Peru.(3)Breast Cancer Translational Research Laboratory, Institut Jules Bordet,Brussels, Belgium.(4)Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center,Vanderbilt University, Nashville, Tennessee, USA.(5)Escuela de Medicina Humana, Universidad Privada San Juan Bautista, Av. JoséAntonio Lavalle s/n Hacienda Villa, Chorrillos, Lima 09, Peru.(6)Grupo de Estudios Clínicos Peruano Oncológico (GECOPERU), Calle Tinajones 177,Surco, Lima, Peru.(7)Departamento de Oncología Médica, Instituto Nacional de EnfermedadesNeoplasicas, Lima, Peru.(8)Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA, Lima, Peru.hgomezmoreno@gmail.com.(9)Departamento de Oncología Médica, Instituto Nacional de EnfermedadesNeoplasicas, Lima, Peru. hgomezmoreno@gmail.com.Triple negative breast cancer (TNBC) is the most aggressive form of breast cancerwith limited options of targeted therapy. Recent findings suggest that theclinical course of TNBC may be modified by the presence of tumor-infiltratinglymphocytes (TILs) and chemokine's expression, such as CCL5. Diverse studies haveshown that CCL5 suppresses anti-tumor immunity and it has been related to pooroutcome in different types of cancer while in other studies, this gene has beenrelated with a better outcome. We sought to determine the association of CCL5with the recruitment of TILs and other immune cells. With this aim we evaluated aretrospective cohort of 72 TNBC patients as well as publicly available datasets. TILs were correlated with residual tumor size after neoadjuvant chemotherapy(NAC) and CCL5 expression. In univariate analysis, TILs and CCL5 were bothassociated to the distant recurrence free survival; however, in a multivariateanalysis, TILs was the only significant marker (HR = 0.336; 95%IC: 0.150-0.753;P = 0.008). CIBERSORT analysis suggested that a high CCL5 expression wasassociated with recruitment of CD8 T cells, CD4 activated T cells, NK activatedcells and macrophages M1. The CD8A gene (encoding for CD8) was associated with animproved outcome in several public breast cancer datasets.DOI: 10.1038/s41598-018-23099-7 PMCID: PMC5861063PMID: 29559701 